Series C funding round for Kinnate Biopharma raising $98M in August 2020
Series C funding round for Kinnate Biopharma raising $98M in August 2020
| Investor | Firm Type | Partner |
|---|
| Private | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Investment Bank | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$195M
Top Valuation
-
Kinnate Biopharma raised $98M in a Series C round.
The round was announced on 08/01/20.
The round was led by Peter Kolchinsky.